Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

  • The following term was not found in PubMed: Oyawa.
1.

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.

Lissitchkov T, Klukowska A, Pasi J, Kessler CM, Klamroth R, Liesner RJ, Belyanskaya L, Walter O, Knaub S, Bichler J, Jansen M, Oldenburg J.

Ther Adv Hematol. 2019 Jun 26;10:2040620719858471. doi: 10.1177/2040620719858471. eCollection 2019. Review.

2.

Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool.

Sakhdari A, Moghaddam PA, Ok CY, Walter O, Tomaszewicz K, Caporelli ML, Meng X, LaFemina J, Whalen G, Belkin E, Zivny J, Wassef W, Woda BA, Hutchinson LM, Cosar EF.

Oncotarget. 2019 Jun 18;10(40):4026-4037. doi: 10.18632/oncotarget.26999. eCollection 2019 Jun 18.

3.

Understanding Determinants of Carbohydrate Metabolism and Their Contribution to Metabolic Health; The Impact of AMY1 CNV (P21-015-19).

O'Callaghan N, Valsesia A, Kulkarni S, Marquis J, Leone P, Mironova P, Walter O, Saris W, Descombes P, Hager J, Saris W, Astrup A, Darimont C.

Curr Dev Nutr. 2019 Jun 13;3(Suppl 1). pii: nzz041.P21-015-19. doi: 10.1093/cdn/nzz041.P21-015-19. eCollection 2019 Jun.

4.

Paraganglioma of the testicle: A case presentation and review of the literature.

Kim JK, Baumgarten A, Walter O, Patel T.

Urol Case Rep. 2019 Feb 15;24:100847. doi: 10.1016/j.eucr.2019.100847. eCollection 2019 May.

5.

Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.

Tiefenbacher S, Albisetti M, Baker P, Kappert G, Kitchen S, Kremer Hovinga JA, Pouplard C, Scholz U, Ternisien C, Borgvall C, Vicente T, Belyanskaya L, Walter O, Oldenburg J; Nuwiq Field Study Participating Laboratories.

Haemophilia. 2019 May 20. doi: 10.1111/hae.13763. [Epub ahead of print]

PMID:
31106957
6.

Salivary α-amylase copy number is not associated with weight trajectories and glycemic improvements following clinical weight loss: results from a 2-phase dietary intervention study.

Valsesia A, Kulkarni SS, Marquis J, Leone P, Mironova P, Walter O, Hjorth MF, Descombes P, Hager J, Saris WH, Astrup A, Darimont C, O'Callaghan NJ.

Am J Clin Nutr. 2019 Apr 1;109(4):1029-1037. doi: 10.1093/ajcn/nqy363.

PMID:
30982860
7.

Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.

Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, Delobel P, Liblau R, Martin-Blondel G; Immune Checkpoint Inhibitors in PML Study Group.

N Engl J Med. 2019 Apr 25;380(17):1674-1676. doi: 10.1056/NEJMc1816198. Epub 2019 Apr 10. No abstract available.

PMID:
30969500
8.

Minimal Associations Between Clinical Data and Children's Self-Reported Health-Related Quality of Life in Children With Chronic Conditions-A Cross-Sectional Study.

Fischer KI, Barthel D, Otto C, Ravens-Sieberer U, Thyen U, Klein M, Walter O, Rose M, Nolte S.

Front Pediatr. 2019 Feb 5;7:17. doi: 10.3389/fped.2019.00017. eCollection 2019.

9.

Genome-wide gene-based analyses of weight loss interventions identify a potential role for NKX6.3 in metabolism.

Valsesia A, Wang QP, Gheldof N, Carayol J, Ruffieux H, Clark T, Shenton V, Oyston LJ, Lefebvre G, Metairon S, Chabert C, Walter O, Mironova P, Lau P, Descombes P, Viguerie N, Langin D, Harper ME, Astrup A, Saris WH, Dent R, Neely GG, Hager J.

Nat Commun. 2019 Feb 1;10(1):540. doi: 10.1038/s41467-019-08492-8.

10.

Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.

Zhu X, Salhab M, Tomaszewicz K, Meng X, Mathew C, Bathini V, Switzer B, Walter O, Cosar EF, Wang X, Lambert LA, Hutchinson LM.

Hum Pathol. 2019 Mar;85:260-269. doi: 10.1016/j.humpath.2018.11.011. Epub 2018 Nov 17.

PMID:
30458197
11.

PET imaging of sympathetic innervation with [18F]Flurobenguan vs [11C]mHED in a patient with ischemic cardiomyopathy.

Zelt JGE, Mielniczuk LM, Orlandi C, Robinson S, Hadizad T, Walter O, Garrard L, Beanlands RSB, deKemp RA.

J Nucl Cardiol. 2018 Nov 19. doi: 10.1007/s12350-018-01527-5. [Epub ahead of print] No abstract available.

PMID:
30456496
12.

Actinide Organometallic Complexes with π-Ligands.

Walter O.

Chemistry. 2019 Feb 26;25(12):2927-2934. doi: 10.1002/chem.201803413. Epub 2018 Dec 18. Review.

13.

Surprising Advantages of Low Self-Efficacy Revealed in a Sports Nutrition Education.

Walter O, Bobrov A, Tamir S.

Am J Health Behav. 2018 Jul 1;42(4):23-33. doi: 10.5993/AJHB.42.4.3.

PMID:
29973308
14.

Physical Activity Intensity Among Adolescents and Association With Parent-Adolescent Relationship and Well-Being.

Shennar-Golan V, Walter O.

Am J Mens Health. 2018 Sep;12(5):1530-1540. doi: 10.1177/1557988318768600. Epub 2018 May 3.

15.

Predictors of health-related quality of life in chronically ill children and adolescents over time.

Barthel D, Ravens-Sieberer U, Nolte S, Thyen U, Klein M, Walter O, Meyrose AK, Rose M, Otto C.

J Psychosom Res. 2018 Jun;109:63-70. doi: 10.1016/j.jpsychores.2018.03.005. Epub 2018 Mar 14.

PMID:
29580563
16.

Unexpected Behavior of Np in Oxo-selenate/Oxo-selenite Systems.

Langer EM, Walter O, Colle JY, Bosbach D, Alekseev EV.

Inorg Chem. 2018 Feb 5;57(3):1604-1613. doi: 10.1021/acs.inorgchem.7b02961. Epub 2018 Jan 22.

PMID:
29355311
17.

Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate® : Final report from a prospective study.

Klukowska A, Komrska V, Vdovin V, Pavlova A, Jansen M, Lowndes S, Belyanskaya L, Walter O, Laguna P.

Haemophilia. 2018 Mar;24(2):221-228. doi: 10.1111/hae.13385. Epub 2018 Jan 3.

PMID:
29314439
18.

Solid-State Structure of Tris-Cyclopentadienide Uranium(III) and Plutonium(III).

Apostolidis C, Dutkiewicz MS, Kovács A, Walter O.

Chemistry. 2018 Feb 26;24(12):2841-2844. doi: 10.1002/chem.201704845. Epub 2017 Dec 27.

19.

Organometallic Neptunium Chemistry.

Arnold PL, Dutkiewicz MS, Walter O.

Chem Rev. 2017 Sep 13;117(17):11460-11475. doi: 10.1021/acs.chemrev.7b00192. Epub 2017 Aug 30.

PMID:
28853564
20.

Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.

Liesner RJ, Abashidze M, Aleinikova O, Altisent C, Belletrutti MJ, Borel-Derlon A, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Fouzia NA, Gattens M, Gruel Y, Guillet B, Kavardakova N, El Khorassani M, Klukowska A, Lambert T, Lohade S, Sigaud M, Turea V, Wu JKM, Vdovin V, Pavlova A, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ.

Haemophilia. 2018 Mar;24(2):211-220. doi: 10.1111/hae.13320. Epub 2017 Aug 16.

PMID:
28815880

Supplemental Content

Loading ...
Support Center